达夫尼丁通过抑制T细胞激活和随后的JAK/STAT6信号传递来缓解过敏呼吸道炎症
Ji-Yoon Park1, Jae-Won Lee2, Eun Sol Oh3
1Natural Product Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, 28116, Republic of Korea; Department of Anatomy & Cell Biology, Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, 35015, Republic of Korea.
European journal of pharmacology
|July 21, 2024
概括
来自Daphne kiusiana的达夫尼丁通过稳定和抑制JAK/STAT6通路来抑制过敏呼吸道炎症. 这种天然化合物显示出作为一种替代性喘治疗的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 过敏性喘是一种慢性呼吸道疾病,造成严重的健康负担.
- 达芬妮基苏安娜 (Daphne kiusiana Miquel) 是一种药用植物,具有潜在的抗炎性质.
- 在过敏性喘中D. kiusiana的分子机制尚未完全理解.
研究的目的:
- 阐明Daphne kiusiana及其化合物达芬尼因抑制过敏呼吸道炎症的分子机制.
- 在体外和体内评估D. kiusiana和达芬尼丁乙烯酸乙烯酸分离物的抗炎作用.
主要方法:
- 评估了D. kiusiana乙酸盐分和达芬尼因对小鼠T淋巴细胞EL4细胞和卵胺诱导的喘小鼠的影响.
- 评估了T助手2型 (Th2) 细胞因子分泌,免疫球蛋白E的产生,粘液分泌和炎症细胞的招募.
- 研究了达芬尼对细胞内Ca2+调动,激活蛋白1 (IL) -4,IL-13,简氏激酶 (JAK) /信号转换器和转录6 (STAT6) 信号的激活器,以及STAT6目标基因 (GATA3,PDEF) 的影响.
主要成果:
- 在喘小鼠中,D. kiusiana提取物和达芬尼因抑制了Th2细胞因子分泌,IgE产生,粘液分泌和炎症细胞透.
- 在体外,达芬尼丁抑制了细胞内Ca2+调动和激活蛋白1活性,减少了IL-4和IL-13的表达.
- 达夫尼丁抑制了IL-4/-13诱导的JAK/STAT6信号传递,降低了GATA3和PDEF的表达,这是Th2细胞因子和粘蛋白的关键调节者.
结论:
- 达夫尼丁通过稳定细胞内Ca2+水平并抑制JAK/STAT6/GATA3/PDEF通路来抑制过敏气道炎症.
- 这些发现表明,达芬尼是过敏性喘的潜在治疗剂.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
01:19Antiasthma Drugs: Leukotriene Modifiers
269
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
269
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267
01:20Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
02:06Allergic Reactions
27.3K
Overview
27.3K
01:20Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K